NCT04534036View on ClinicalTrials.gov

Tolerability and Functional Assessment of a Novel Children's Synbiotic

NACompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

August 13, 2020

Primary Completion Date

January 14, 2022

Study Completion Date

February 10, 2022

Conditions
ConstipationSigns and SymptomsDigestive Signs and SymptomsInfrequent or Difficult Evacuation
Interventions
DIETARY_SUPPLEMENT

PDS-08

PDS-08 is a novel synbiotic comprised of nine probiotic bacterial strains and FOS-inulin as a prebiotic.

OTHER

Placebo

Placebo sachets will contain potato or tapioca maltodextrin.

Trial Locations (1)

94103-3627

Curebase, Inc., San Francisco

All Listed Sponsors
collaborator

Curebase Inc.

INDUSTRY

lead

Seed Health

INDUSTRY

NCT04534036 - Tolerability and Functional Assessment of a Novel Children's Synbiotic | Biotech Hunter | Biotech Hunter